jama glp-1 Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control This one has been on

People who develop fat-adapted metabolism, learn keto food preparation, and build sustainable ketogenic eating patterns during their semaglutide course have a functional maintenance strategy available when they eventually taper off

The SELECT trial (Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity), completed in 2023 with over 17,600 participants, demonstrated a 20% reduction in major adverse cardiovascular events in patients with established cardiovascular disease and overweight or obesity but without diabetes

Think of it like this your kidney becomes a sugar drain

By mimicking the effects of the naturally occurring GLP-1 hormone, liraglutide helps regulate blood sugar levels, enhance insulin secretion, and reduce appetite, making it an effective option for those struggling with metabolic disorders